Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter - Thursday, December 19, 2024.
Stock Region Penny Picks Watchlist Newsletter - Thursday, December 19, 2024
Disclaimer: This newsletter is for educational and informational purposes only. It should not be considered financial advice. Always conduct your own research or consult a financial professional before making investment decisions. Stock performance in the past does not guarantee future results.
$VGAS - Verde Clean Fuels, Inc.
Verde Clean Fuels announced a $50 million equity investment by Cottonmouth Ventures, LLC, a subsidiary of Diamondback Energy, Inc. This significant investment could enhance the company’s capabilities in clean energy solutions and increase its valuation prospects.
$BPTH - Bio-Path Holdings
Bio-Path Holdings revealed promising preclinical testing results for BP1001-A in treating obesity for Type 2 diabetes patients. By enhancing insulin sensitivity, this treatment may offer a breakthrough in diabetes care. Shares currently trading at $0.7468.
$VRAR - Brightline Interactive
Brightline Interactive has entered into a contract with the U.S. Navy to develop an immersive, AI-driven simulator system. This agreement highlights the company’s innovation in defense-related technology, which could position it for future growth.
$PTN - Palatin
Palatin shared successful Phase IIb study results for Type 2 Diabetic Nephropathy treatment. These findings showcase the company’s progress in addressing complications of diabetes, with shares trading at $0.9080.
$PHIO - Phio Pharmaceuticals
Phio Pharmaceuticals received a green light from the Safety Monitoring Committee to continue its clinical trial for PH-762. This advancement signals confidence in the safety profile of its cancer treatment therapy.
$UAVS - AgEagle Aerial Systems
AgEagle Aerial Systems secured a milestone order for 60 RedEdge-P multispectral sensors. This could strengthen its position in the agricultural and environmental sectors.
$CGTX - Cognition Therapeutics
Chardan Capital reaffirmed its "Buy" rating for Cognition Therapeutics, maintaining a price target of $11. Shares are currently at $0.75. Investors could view this as an opportunity to capitalize on potential upward movement.
$IMNN - IMUNON
IMUNON announced a positive meeting with the FDA for IMNN-001, its treatment for advanced ovarian cancer. Coupled with after-hours volume increases and a $12 price target from HC Wainwright, this stock is seeing rising investor interest.
$TOMZ - TOMI Environmental
TOMI Environmental emphasized its readiness to protect public health during the H5N1 bird flu emergency in California. Its innovative solutions could play a crucial role in addressing this public health challenge.
$TPET - Trio Petroleum
Trio Petroleum is set to acquire producing oil and gas assets in the heavy oil region of Saskatchewan, Canada. This move may bolster its production capabilities and project portfolio.
$ISPO - Inspirato
Inspirato’s Chairman and CEO, Payam Zamani, increased his ownership significantly by acquiring additional shares through various means, including a $600,000 cash conversion and $350,000 in open market purchases. This demonstrates strong insider confidence in the company’s future.
$MODD - Modular Medical
Modular Medical has entered into a licensing and partnership deal with Nudge BG, advancing its offering in diabetes management technologies.
$APTO - Aptose
Aptose received positive news from Nasdaq Hearings Panel regarding compliance with the Minimum Bid Price rule. To meet this, the stock must close at or above $1.00 for 10 consecutive business days by March 31, 2025. Shares currently trade at $0.2150.
$SQFT - Presidio Property Trust
Presidio Property Trust updated its share repurchase program, authorizing up to $6 million for Series A Common Stock and $4 million for Series D Preferred Stock repurchases.
$MGRX - Mangoceuticals, Inc.
Mangoceuticals signed a Patent Purchase Agreement to acquire patents related to fungal-based nutraceutical compositions. This acquisition signals its commitment to innovation in the health and wellness space. Note: MGRX completed a reverse split in October at a 1:15 ratio.
Closing Disclaimer: This newsletter provides highlights for investors to consider but does not constitute financial advice. Always assess your own investment goals and risk tolerance before taking action. Past performance is not a guarantee of future outcomes.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net